[YMAB] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -23.64%
YoY- 85.11%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 19,931 23,363 20,454 20,751 20,251 31,447 12,537 36.17%
PBT -6,469 -793 -7,560 -6,123 -6,390 1,157 -27,526 -61.88%
Tax 160 195 187 179 -1,293 1,558 1,509 -77.56%
NP -6,629 -988 -7,747 -6,302 -5,097 -401 -29,035 -62.61%
Tax Rate - - - - - -134.66% - -
Total Cost 26,560 24,351 28,201 27,053 25,348 31,848 41,572 -25.80%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -33.26 -4.23 -37.88 -30.37 -25.17 -1.28 -231.59 -72.54%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.15 -0.02 -0.18 -0.14 -0.12 -0.01 -0.66 -62.72%
EPS Diluted -0.15 -0.02 -0.18 -0.14 -0.12 -0.01 -0.66 -62.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.